» Articles » PMID: 38339074

Apolipoprotein E Gene in α-Synucleinopathies: A Narrative Review

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Feb 10
PMID 38339074
Authors
Affiliations
Soon will be listed here.
Abstract

In this narrative review, we delved into the intricate interplay between alleles (typically associated with Alzheimer's disease-AD) and alpha-synucleinopathies (aS-pathies), involving Parkinson's disease (PD), Parkinson's disease dementia (PDD), dementia with Lewy bodies (DLB), and multiple-system atrophy (MSA). First, in-vitro, animal, and human-based data on the exacerbating effect of on LB pathology were summarized. We found robust evidence that carriage constitutes a risk factor for PDD-APOE2, and APOE3 may not alter the risk of developing PDD. We confirmed that copies confer an increased hazard towards DLB, as well. Again and appear unrelated to the risk of conversion. Of note, in individuals with DLB , carriage appears to be intermediately prevalent between AD and PDD-PD (AD > DLB > PDD > PD). Less consistency existed when it came to PD; -PD associations tended to be markedly modified by ethnicity. Finally, we failed to establish an association between the gene and MSA. Phenotypic associations (age of disease onset, survival, cognitive-neuropsychiatric- motor-, and sleep-related manifestations) between alleles, and each of the aforementioned conditions were also outlined. Finally, a synopsis of literature gaps was provided followed by suggestions for future research.

Citing Articles

Spectrum and Prevalence of Rare Variants and Their Association with Familial Dysbetalipoproteinemia.

Blokhina A, Ershova A, Kiseleva A, Sotnikova E, Zharikova A, Zaicenoka M Int J Mol Sci. 2024; 25(23).

PMID: 39684364 PMC: 11641494. DOI: 10.3390/ijms252312651.


Protective Effects of Ambroxol on Aβ and α-Synuclein-Induced Neurotoxicity Through Glucocerebrosidase Activation in HT-22 Hippocampal Neuronal Cells.

Lin S, Chang C, Tsou S, Chiu P, Cheng J, Hung H Int J Mol Sci. 2024; 25(22).

PMID: 39596182 PMC: 11593818. DOI: 10.3390/ijms252212114.


More evidence for widespread antagonistic pleiotropy in polymorphic disease alleles.

Lockwood C, Vo A, Bellafard H, Carter A Front Genet. 2024; 15:1404516.

PMID: 38952711 PMC: 11215129. DOI: 10.3389/fgene.2024.1404516.

References
1.
Lopez M, Guerrero J, Yescas P, Boll M, Familiar I, Ochoa A . Apolipoprotein E epsilon4 allele is associated with Parkinson disease risk in a Mexican Mestizo population. Mov Disord. 2007; 22(3):417-20. DOI: 10.1002/mds.21340. View

2.
McKeith I, Boeve B, Dickson D, Halliday G, Taylor J, Weintraub D . Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017; 89(1):88-100. PMC: 5496518. DOI: 10.1212/WNL.0000000000004058. View

3.
Vijayaraghavan S, Darreh-Shori T, Rongve A, Berge G, Sando S, White L . Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease. J Alzheimers Dis. 2016; 50(2):567-76. DOI: 10.3233/JAD-150750. View

4.
Gearing M, Schneider J, Rebeck G, Hyman B, Mirra S . Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates. Neurology. 1995; 45(11):1985-90. DOI: 10.1212/wnl.45.11.1985. View

5.
Morris C, Massey H, Benjamin R, Leake A, Broadbent C, Griffiths M . Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias. J Neural Transm Suppl. 1996; 47:205-18. DOI: 10.1007/978-3-7091-6892-9_14. View